206 related articles for article (PubMed ID: 9160598)
1. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
2. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
3. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
4. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
5. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
6. High doses alprazolam induced amenorrhoea and galactorrhoea.
Petrić D; Peitl MV; Peitl V
Psychiatr Danub; 2011 Mar; 23(1):123-4. PubMed ID: 21448116
[TBL] [Abstract][Full Text] [Related]
7. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
8. [Clinical picture and treatment of agoraphobia with panic disorder].
Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
[No Abstract] [Full Text] [Related]
9. Treatment of panic disorder and agoraphobia with clonazepam.
Spier SA; Tesar GE; Rosenbaum JF; Woods SW
J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
[TBL] [Abstract][Full Text] [Related]
10. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders.
Márquez M; Arenoso H; Caruso N
Actas Esp Psiquiatr; 2011; 39(2):88-94. PubMed ID: 21404147
[TBL] [Abstract][Full Text] [Related]
13. Xanax XR for panic disorder.
Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
[No Abstract] [Full Text] [Related]
14. Pharmacotherapeutic considerations in anxiety disorders.
Hollister LE
J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam treatment for panic disorders.
Alexander PE; Alexander DD
J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
[TBL] [Abstract][Full Text] [Related]
16. Gepirone and the treatment of panic disorder: an open study.
Pecknold JC; Luthe L; Scott-Fleury MH; Jenkins S
J Clin Psychopharmacol; 1993 Apr; 13(2):145-9. PubMed ID: 8096526
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of panic disorder. Reply to comment by Marks and associates.
Klerman GL
Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
[No Abstract] [Full Text] [Related]
18. Switching patients from alprazolam to clonazepam.
Rosenbaum JF
Hosp Community Psychiatry; 1990 Dec; 41(12):1302, 1305. PubMed ID: 2276722
[No Abstract] [Full Text] [Related]
19. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Klein E; Malel D; Zilberman I; Lenox RH
Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
[TBL] [Abstract][Full Text] [Related]
20. Functional classification of anxiety-panic.
Liebowitz MR
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():47-52. PubMed ID: 7902853
[No Abstract] [Full Text] [Related]
[Next] [New Search]